These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 15650997)

  • 1. Pro: Ischemic preconditioning has a myocardial protective effect during coronary artery bypass surgery.
    Tarkka MR
    J Cardiothorac Vasc Anesth; 2004 Dec; 18(6):799-802. PubMed ID: 15650997
    [No Abstract]   [Full Text] [Related]  

  • 2. Con: Ischemic preconditioning is not necessary because volatile agents accomplish it.
    Piriou V; Chiari P
    J Cardiothorac Vasc Anesth; 2004 Dec; 18(6):803-5. PubMed ID: 15650998
    [No Abstract]   [Full Text] [Related]  

  • 3. Isoflurane preconditioning-induced cardio-protection in patients undergoing coronary artery bypass grafting.
    Lee MC; Chen CH; Kuo MC; Kang PL; Lo A; Liu K
    Eur J Anaesthesiol; 2006 Oct; 23(10):841-7. PubMed ID: 16507192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological preconditioning of the heart during surgery.
    Landoni G; Figini F; Bignami E
    Eur J Cardiothorac Surg; 2010 Apr; 37(4):982-3; author reply 983. PubMed ID: 19853466
    [No Abstract]   [Full Text] [Related]  

  • 5. Rationale, design and baseline characteristics of the PRO-TECT II study: PROpofol CardioproTECTion for Type II diabetics: a randomized, controlled trial of high-dose propofol versus isoflurane preconditioning in patients undergoing on-pump coronary artery bypass graft surgery.
    Ansley DM; Raedschelders K; Chen DD; Choi PT
    Contemp Clin Trials; 2009 Jul; 30(4):380-5. PubMed ID: 19336262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonlinear heart rate variability in CABG patients and the preconditioning effect.
    Wu ZK; Vikman S; Laurikka J; Pehkonen E; Iivainen T; Huikuri HV; Tarkka MR
    Eur J Cardiothorac Surg; 2005 Jul; 28(1):109-13. PubMed ID: 15982594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Remote ischaemic preconditioning: the current best hope for improved myocardial protection in cardiac surgery?
    Rahman I; Bonser RS
    Heart; 2009 Oct; 95(19):1553-5. PubMed ID: 19628467
    [No Abstract]   [Full Text] [Related]  

  • 8. Preconditioning and the human heart.
    Rezkalla SH; Kloner RA
    Panminerva Med; 2005 Jun; 47(2):69-73. PubMed ID: 16210991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Desflurane preconditioning in coronary artery bypass graft surgery: a double-blinded, randomised and placebo-controlled study.
    Meco M; Cirri S; Gallazzi C; Magnani G; Cosseta D
    Eur J Cardiothorac Surg; 2007 Aug; 32(2):319-25. PubMed ID: 17574858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation by cardiac troponin I: the effect of ischemic preconditioning as an adjunct to intermittent blood cardioplegia on coronary artery bypass grafting.
    Ji B; Liu M; Liu J; Wang G; Feng W; Lu F; Shengshou H
    J Card Surg; 2007; 22(5):394-400. PubMed ID: 17803575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human adaptation to ischemia by preconditioning or unstable angina: involvement of nuclear factor kappa B, but not hypoxia-inducible factor 1 alpha in the heart.
    Czibik G; Wu Z; Berne GP; Tarkka M; Vaage J; Laurikka J; Järvinen O; Valen G
    Eur J Cardiothorac Surg; 2008 Nov; 34(5):976-84. PubMed ID: 18842422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is remote ischemic preconditioning triggered by intermittent claudication secondary to peripheral arterial disease responsible for preventing early mortality after coronary artery bypass surgery?
    Ozeke O; Gungor M; Ozer C
    Ann Thorac Surg; 2011 Jan; 91(1):333-4. PubMed ID: 21172560
    [No Abstract]   [Full Text] [Related]  

  • 13. Impact of preconditioning protocol on anesthetic-induced cardioprotection in patients having coronary artery bypass surgery.
    Frässdorf J; Borowski A; Ebel D; Feindt P; Hermes M; Meemann T; Weber R; Müllenheim J; Weber NC; Preckel B; Schlack W
    J Thorac Cardiovasc Surg; 2009 Jun; 137(6):1436-42, 1442.e1-2. PubMed ID: 19464461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myocardial metabolism altered by ischemic preconditioning and enflurane in off-pump coronary artery surgery.
    Drenger B; Gilon D; Chevion M; Elami A; Meroz Y; Milgalter E; Gozal Y
    J Cardiothorac Vasc Anesth; 2008 Jun; 22(3):369-76. PubMed ID: 18503923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The potential of pre and post conditioning to prevent cardiac ischemic sequelae.
    Meijer RC; Kappetein AP; Serruys PW; Bogers JJ
    Wien Klin Wochenschr; 2007; 119(11-12 Suppl 1):21-3. PubMed ID: 19618594
    [No Abstract]   [Full Text] [Related]  

  • 16. Changes in noninfarcted myocardium explain benefits of on-pump beating-heart coronary artery bypass grafting for acute myocardial infarction.
    Varatharajah K; Rosenfeldt FL
    J Thorac Cardiovasc Surg; 2009 Jun; 137(6):1575-6; author reply 1576-7. PubMed ID: 19464495
    [No Abstract]   [Full Text] [Related]  

  • 17. Remote ischaemic preconditioning of the heart: remote questions, remote importance, or remote preconditions?
    Peters J
    Basic Res Cardiol; 2011 Jun; 106(4):507-9. PubMed ID: 21544681
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacological preconditioning with hyperbaric oxygen: can this therapy attenuate myocardial ischemic reperfusion injury and induce myocardial protection via nitric oxide?
    Yogaratnam JZ; Laden G; Guvendik L; Cowen M; Cale A; Griffin S
    J Surg Res; 2008 Sep; 149(1):155-64. PubMed ID: 17996900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical applicability of preconditioning and postconditioning: the cardiothoracic surgeons's view.
    Ramzy D; Rao V; Weisel RD
    Cardiovasc Res; 2006 May; 70(2):174-80. PubMed ID: 16524563
    [No Abstract]   [Full Text] [Related]  

  • 20. Endogenous cannabinoids contribute to remote ischemic preconditioning via cannabinoid CB2 receptors in the rat heart.
    Hajrasouliha AR; Tavakoli S; Ghasemi M; Jabehdar-Maralani P; Sadeghipour H; Ebrahimi F; Dehpour AR
    Eur J Pharmacol; 2008 Jan; 579(1-3):246-52. PubMed ID: 17950273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.